GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Schott Pharma AG & CO KGaA (WBO:1SXP) » Definitions » Scaled Net Operating Assets

Schott Pharma AG KGaA (WBO:1SXP) Scaled Net Operating Assets : 0.54 (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Schott Pharma AG KGaA Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Schott Pharma AG KGaA's operating assets for the quarter that ended in Jun. 2024 was €1,369.5 Mil. Schott Pharma AG KGaA's operating liabilities for the quarter that ended in Jun. 2024 was €629.7 Mil. Schott Pharma AG KGaA's Total Assets for the quarter that ended in Mar. 2024 was €1,359.0 Mil. Therefore, Schott Pharma AG KGaA's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2024 was 0.54.


Schott Pharma AG KGaA Scaled Net Operating Assets Historical Data

The historical data trend for Schott Pharma AG KGaA's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Schott Pharma AG KGaA Scaled Net Operating Assets Chart

Schott Pharma AG KGaA Annual Data
Trend Sep20 Sep21 Sep22 Sep23
Scaled Net Operating Assets
0.51 0.66 1.02 0.62

Schott Pharma AG KGaA Quarterly Data
Sep20 Sep21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - 0.64 0.56 0.62 0.54

Competitive Comparison of Schott Pharma AG KGaA's Scaled Net Operating Assets

For the Medical Instruments & Supplies subindustry, Schott Pharma AG KGaA's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Schott Pharma AG KGaA's Scaled Net Operating Assets Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Schott Pharma AG KGaA's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Schott Pharma AG KGaA's Scaled Net Operating Assets falls into.



Schott Pharma AG KGaA Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Schott Pharma AG KGaA's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Sep. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Sep. 2023 )
=(Operating Assets (A: Sep. 2023 )-Operating Liabilities (A: Sep. 2023 ))/Total Assets (A: Sep. 2022 )
=(1205.939-467.318)/1196.5
=0.62

where

Operating Assets(A: Sep. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=1231.828 - 25.889
=1205.939

Operating Liabilities(A: Sep. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=539.649 - 69.193 - 3.138
=467.318

Schott Pharma AG KGaA's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Jun. 2024 )
=(Operating Assets (Q: Jun. 2024 )-Operating Liabilities (Q: Jun. 2024 ))/Total Assets (Q: Mar. 2024 )
=(1369.512-629.728)/1359.048
=0.54

where

Operating Assets(Q: Jun. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=1399.033 - 29.521
=1369.512

Operating Liabilities(Q: Jun. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=629.728 - 0 - 0
=629.728

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Schott Pharma AG KGaA Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Schott Pharma AG KGaA's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Schott Pharma AG KGaA Business Description

Traded in Other Exchanges
Address
Hattenbergstrasse 10, Mainz, RP, DEU, 55122
Schott Pharma AG & CO KGaA caters to the pharma, biotech and life science industry by providing containment solutions and delivery systems for injectable drugs. Its segments include; Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of the revenue is generated from Drug Containment Solutions segment which includes products like vials, cartridges and ampoules for safe drug containment. Geographically, the company generates revenue from Europe, Middle East, Africa (EMEA), Asia and South Pacific, North America and South America.

Schott Pharma AG KGaA Headlines

No Headlines